|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,931.50 GBX | -0.44% |
|
+0.63% | +5.86% |
| 31/07 | Drugmakers, retailers must face 'maximum strength' claim in decongestant false ad litigation in US | RE |
| 31/07 | GSK global supply chain director sells 38,000 shares | AN |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 2,029 | 2,268 | 2,213 |
| Spread/Res. | -4.81% | -14.84% | -12.72% |
| Spread/Supp. | +2.63% | +6.10% | +7.25% |
| Support | 1,882 | 1,820.5 | 1,801 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GSK Stock
- Charts GSK plc
Select your edition
All financial news and data tailored to specific country editions
